HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.

AuthorsR Kanamaru, A Wakui, C Ishioka, M Okuno, Y Konishi, A Ishikawa, H Shibata
JournalThe science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku (Sci Rep Res Inst Tohoku Univ Med) Vol. 35 Issue 1-4 Pg. 35-40 (Dec 1988) ISSN: 0371-2761 [Print] Japan
PMID3267125 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin G
  • Immunotoxins
  • Prednisolone
  • Melphalan
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Female
  • Humans
  • Immunoglobulin G (administration & dosage)
  • Immunotoxins (therapeutic use)
  • Male
  • Melphalan (administration & dosage)
  • Middle Aged
  • Multiple Myeloma (drug therapy)
  • Prednisolone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: